A Centers for Disease Control and Prevention vaccine advisory committee meeting scheduled for next week — the first since ...

(Reuters) - A meeting of U.S. vaccine advisers set for late February has been postponed, a federal official confirmed on Thursday, raising new uncertainty about the Trump administration's vaccine ...

Less than a week after newly confirmed Department of Health and Human Services (HHS) secretary Robert F. Kennedy Jr. | Less than a week after newly confirmed HHS secretary Robert F. Kennedy Jr.

A panel of experts advising the U.S. Centers for Disease Control and Prevention on vaccines will not convene for its February ...

A meeting of vaccine advisers set for late February has been postponed, a federal official confirmed on Thursday, raising new ...

The CDC's Advisory Committee on Immunization Practices was set to meet beginning February 26 and provide recommendations ...

GSK (GSK) announced that the China National Medical Products Administration, CNMPA, has accepted for review the new drug application for the ...

The U.S. Food and Drug Administration has approved Penmenvy (Meningococcal Groups A, B, C, W, and Y Vaccine) for active ...

Penmenvy, which protects against five common types of disease-causing bacteria, is cleared for use in people aged 10 through ...

Thousands of U.S. health agency employees were terminated and told it was for poor performance, though they'd received strong ...

GSK's Penmenvy wins FDA approval to protect against five meningococcal serogroups. The CDC panel will vote on usage ...